Nisha Patel, MD
Allergy/Immunology · San Mateo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
- Since medical school
- 19 years
- Graduated 2007
Offices
1 location · Csi Medical Group · 104 clinicians in this group
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Patel’s office at (650) 348-1242 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
State licence records
1 licence
- Florida ME119949Medical Doctor · since 2014 · expires 2028-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- Allergy And Immunology
Education
- St. George'S University · MD2003–2007Medical school
- University of South Florida College of Medicine · Bachelor Degree1999–2003
Residency and fellowship
- Thomas Jefferson University, Allergy and ImmunologyPHILADELPHIA, US · 2012–2014
- Crozer Chester Medical Center, Internal Medicine/Family PracticeUPLAND, US · 2007–2010
What else the board holds
Also licensed in
States the clinician told their board they are also licensed in. Only the states we check are verified.
Delaware · Florida · Pennsylvania
Drugs they prescribed that Part D paid
$10,860
Pharmacies billed $10,860 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 45) in 2024. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
34 generic and 11 brand-name prescriptions · $10,860 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
Year by year
| 2024 | 45 | 27 | 0% (0) | 24% | $10,860 |
| 2023 | 133 | 71 | 0% (0) | 19% | $43,939 |
| 2022 | 249 | 114 | 0% (0) | 31% | $101,097 |
| 2021 | 290 | 135 | 0% (0) | 20% | $44,861 |
| 2020 | 20 | None | 0% (0) | None | $1,557 |
| 2019 | 41 | 16 | 0% (0) | 29% | $5,041 |
| 2018 | 82 | 39 | None | None | $18,496 |
| 2017 | 618 | 122 | None | None | $47,984 |
| 2016 | 1,018 | 156 | 8% (86) | None | $73,690 |
| 2015 | 241 | 94 | 13% (31) | 11% | $12,505 |
| 2014 | 31 | None | None | None | $1,671 |
| 2013 | 24 | 18 | None | None | $496 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 3 drugs
| Famotidine | 22 | $323 | $15 |
| Pantoprazole | 12 | $294 | $25 |
| Omeprazole | 27 | $287 | $11 |
2022: 5 drugs
| Zenpep | 21 | $59,398 | $2,828 |
| Linzess | 18 | $11,846 | $658 |
| Omeprazole | 36 | $681 | $19 |
| Pantoprazole | 33 | $593 | $18 |
| Famotidine | 41 | $585 | $14 |
2021: 6 drugs
| Colesevelam | 14 | $7,307 | $522 |
| Epinephrine | 12 | $3,441 | $287 |
| Pantoprazole | 64 | $1,561 | $24 |
| Omeprazole | 41 | $1,094 | $27 |
| Famotidine | 27 | $846 | $31 |
| Hydrocortisone | 14 | $305 | $22 |
2017: 15 drugs
| Symbicort | 25 | $9,613 | $385 |
| Januvia | 11 | $5,701 | $518 |
| Flovent Hfa | 18 | $4,222 | $235 |
| Ventolin Hfa | 18 | $1,205 | $67 |
| Azelastine | 29 | $1,008 | $35 |
| Montelukast | 25 | $304 | $12 |
| Atorvastatin | 25 | $266 | $11 |
| Gabapentin | 19 | $184 | $10 |
| Fluticasone Propionate | 18 | $144 | $8 |
| Amlodipine Besylate | 28 | $127 | $5 |
| Omeprazole | 22 | $124 | $6 |
| Lisinopril | 39 | $113 | $3 |
| Metformin | 28 | $107 | $4 |
| Simvastatin | 11 | $40 | $4 |
| Furosemide | 13 | $32 | $2 |
2016: 30 drugs
| Novolog | 16 | $14,766 | $923 |
| Flovent Hfa | 28 | $7,163 | $256 |
| Ventolin Hfa | 24 | $1,868 | $78 |
| Proair Hfa | 20 | $1,074 | $54 |
| Oxycodone | 24 | $558 | $23 |
| Duloxetine | 14 | $526 | $38 |
| Levothyroxine | 26 | $491 | $19 |
| Oxycodone-Acetaminophen | 13 | $387 | $30 |
| Atorvastatin | 37 | $377 | $10 |
| Methadone | 12 | $368 | $31 |
| Bupropion Xl | 13 | $314 | $24 |
| Montelukast | 25 | $308 | $12 |
| Hydrocodone-Acetaminophen | 11 | $298 | $27 |
| Metoprolol | 13 | $264 | $20 |
| Venlafaxine Hcl Er | 11 | $183 | $17 |
| Tamsulosin | 15 | $170 | $11 |
| Omeprazole | 29 | $144 | $5 |
| Gabapentin | 25 | $140 | $6 |
| Lisinopril | 44 | $123 | $3 |
| Amlodipine Besylate | 36 | $116 | $3 |
| Trazodone | 15 | $107 | $7 |
| Metformin | 26 | $87 | $3 |
| Simvastatin | 15 | $75 | $5 |
| Furosemide | 26 | $73 | $3 |
| Lisinopril-Hydrochlorothiazide | 11 | $66 | $6 |
| Pantoprazole | 11 | $62 | $6 |
| Lorazepam | 20 | $60 | $3 |
| Fluoxetine | 11 | $47 | $4 |
| Citalopram Hbr | 21 | $44 | $2 |
| Meloxicam | 13 | $22 | $2 |
2015: 2 drugs
| Oxybutynin Chloride | 13 | $466 | $36 |
| Tamsulosin | 14 | $211 | $15 |
Money from drug and device companies
$275 in 2025
| 2025 | 3 | 7 | None | $275 |
| 2024 | 2 | 3 | None | $63 |
| 2023 | 1 | 1 | None | $18 |
| 2022 | 3 | 4 | None | $81 |
| 2019 | 4 | 4 | None | $512 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Inspire Medical Systems | Inspire | $141 | 1 payment
|
| Ardelyx | Ibsrela | $117 | 5 payments
|
| OraPharma a division of Bausch Health US | Arestin | $18 | 1 payment
|
See all 7 published payments
| Inspire Medical Systems | Meals · 2025-09-16 | Inspire | $141 |
| Ardelyx | Meals · 2025-06-30 | Ibsrela | $30 |
| Ardelyx | Meals · 2025-05-08 | Ibsrela | $23 |
| Ardelyx | Meals · 2025-04-04 | Ibsrela | $22 |
| Ardelyx | Meals · 2025-03-05 | Ibsrela | $20 |
| Ardelyx | Meals · 2025-02-05 | Ibsrela | $22 |
| OraPharma a division of Bausch Health US | Meals · 2025-01-10 | Arestin | $18 |
See earlier years (2024, 2023, 2022, 2019)
2024: $63
| Ardelyx | Ibsrela | $34 | 2 payments
|
| Gilead Sciences | None | $29 | 1 payment
|
2023: $18
| OraPharma a division of Bausch Health US | Arestin | $18 | 1 payment
|
2022: $81
| kaleo | Auvi-Q | $37 | 2 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $27 | 1 payment
|
| Pharming Healthcare | Ruconest | $16 | 1 payment
|
2019: $512
| Tosoh Bioscience | PA, Aia-Pack Calibrator Set | $382 | 1 payment
|
| AbbVie | None | $100 | 1 payment
|
| Genentech USA | Xolair | $15 | 1 payment
|
| Allergan | Linzess | $15 | 1 payment
|
Professional record
- NPI
- 1336392547
- Licence
- FL ME119949Florida ME119949: Active
- Group
- Csi Medical Group
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RA0201X (207RA0201X)
- Mailing address
- 136 N San Mateo Dr Fl 2, San Mateo, CA, 94401
- NPI first listed
- 2008-10-31
- NPI last updated
- 2026-02-03
- NPI record certified
- 2026-02-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2605 W Swann Ave Ste 600, Tampa, FL, 33609